Mitchell Dean J
SEC-identified person · CIK 1199297 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Theravance Biopharma, Inc. tbph | Director | filed 2014–2026 |
| Praxis Precision Medicines, Inc. PRAX | Director | filed 2020–2026 |
| Kinnate Biopharma Inc. KNTE | Director | filed 2020–2024 |
| Precigen, INC. XON | Director | filed 2013–2024 |
| Immunogen, Inc. IMGN | Director | filed 2012–2024 |
| Ista Pharmaceuticals INC ISTA | Director | filed 2006–2012 |
| Talecris Biotherapeutics Holdings Corp. v9sns*ij | Director | filed 2009–2011 |
| Alpharma INC ALO US | Director · President and CEO | filed 2006–2008 |
| MGI Pharma INC MOGN | Director | filed 2006–2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.